M4MM
The Canadian Workaround: Why U.S. Cannabis Companies May Need a Canadian Entity to Restructure
NEW YORK- Cannabis has produced a workaround that shouldn’t exist—but now does. If you’re a U.S. Cannabis company in distress, you can’t reliably rely on U.S. bankruptcy courts. So an emerging playbook is taking shape: ...
Louisiana Bill Would Tap Opioid Settlement Funds for Psychedelic Therapy Studies
BATON ROUGE – Louisiana lawmakers have advanced legislation that would let the state direct money from opioid lawsuit settlements toward clinical research on psychedelic-assisted therapy. Senate Bill 43, sponsored by Sen. Patrick McMath (R), would ...
India Awards First Public Funding for Cannabis Research in More Than 50 Years
NEW DELHI – The Indian government has awarded public funding to a Cannabis genetics project, the first such grant to a private company since the Narcotic Drugs and Psychotropic Substances Act took effect in 1985. ...
Auxly Reports Q4 and FY 2025 Financial Results
TORONTO – In the Canadian Cannabis industry that continues to reward discipline and brand strength, Auxly Cannabis Group Inc., known for its focus on consumer-packaged goods and leading brands, has posted solid results for the ...
Gilgamesh Pharma Raises $60M to Fund Its Remaining Neuropsychiatric Assets
NEW YORK – Gilgamesh Pharma, the clinical-stage neuroscience company formed last year after AbbVie acquired its predecessor’s lead psychedelic-derived program, announced it had completed an oversubscribed $60 million Series A financing. The round was led ...
The ROI Investors Are Ignoring Within the Cannabis Industry
LOS ANGELES- Industrial hemp has more ROI potential than the medicinal and intoxicating side for a simple reason: industrial hemp is a raw material that can be swapped into enormous existing markets, while medicinal products ...
The 2nd Annual Cannalaugh Kicks Off March 28 in Chicago
CHICAGO- CannaLaugh, a live event series combining nationally touring stand-up comedians with cannabis education, will host its second annual event on March 28. The event, scheduled to take place at the Galleria Chicago at 9 ...
The Canadian Workaround: Why U.S. Cannabis Companies May Need a Canadian Entity to Restructure
NEW YORK- Cannabis has produced a workaround that shouldn’t exist—but now does. If you’re a U.S. Cannabis company in distress, you can’t reliably rely on U.S. bankruptcy courts. So an emerging playbook is taking shape: ...
Louisiana Bill Would Tap Opioid Settlement Funds for Psychedelic Therapy Studies
BATON ROUGE – Louisiana lawmakers have advanced legislation that would let the state direct money from opioid lawsuit settlements toward clinical research on psychedelic-assisted therapy. Senate Bill 43, sponsored by Sen. Patrick McMath (R), would ...
India Awards First Public Funding for Cannabis Research in More Than 50 Years
NEW DELHI – The Indian government has awarded public funding to a Cannabis genetics project, the first such grant to a private company since the Narcotic Drugs and Psychotropic Substances Act took effect in 1985. ...
MindMed Rebrands as Definium Therapeutics, Targets 2026 Trials for LSD-Based Treatments
NEW YORK – Mind Medicine (MindMed) Inc., a developer of treatments derived from psychedelics for mental health conditions, has changed its name to Definium Therapeutics Inc., a move that underscores its push into late-stage testing ...
Sunderstorm Welcomes Lime to Its Family of Brands
LOS ANGELES – Sunderstorm, the California-based Cannabis company behind the popular Kanha edibles line, revealed its purchase of Lime, an expert in pre-rolled joints that has carved out a steady presence in the state's retail ...
Curaleaf Observes Delaware Base to Tighten U.S. Footprint
DOVER – Curaleaf Holdings Inc. has filed for shareholder approval to relocate its corporate domicile from British Columbia, Canada, to Delaware, a change designed to match its heavy concentration of business in the American market. ...
Tilray Brands Reports Q2 Fiscal 2026 Financial Results
NEW YORK – Tilray Brands Inc. posted net revenue of $217.5 million for its fiscal second quarter ended November 30, 2025, marking the company's highest quarterly figure to date and edging up 3% from $211 ...
Helus Pharma Rings Nasdaq Bell Post-Cybin Rebrand
TORONTO – Helus Pharma Inc., rebranded from Cybin Inc., opened trading on the Nasdaq Global Market under the ticker symbol $HELP, marking a shift from the NYSE American where it previously traded as $CYBN. The ...
Who Will Decide Cannabis Legalization? The Math Will.
LOS ANGELES -For decades, Cannabis reform in the United States has moved unevenly—state by state, ballot by ballot, crisis by crisis. On paper, federal prohibition still stands, and national politics remain polarized. But economically and ...
Canopy Growth Locks in Debt Overhaul, Gears Up for Expansion
TORONTO – Canopy Growth Corp. detailed a pair of financial maneuvers aimed at shoring up its books and clearing a path for expansion. The deals, which include a new $150 million U.S. term loan and ...
U.S. Hempcrete Market Set for Steady Rise to $10.6B by 2033
LOS ANGELES – The market for hempcrete, a lightweight composite material derived from the woody core of the hemp plant, stands at $7.83 billion this year and could reach $10.6 billion by 2033. That trajectory ...
From $700 Million Unicorn to Fire-Sale Exit: What the Eaze–Vireo Deal Says About California Cannabis
LOS ANGELES- When Eaze first burst onto the scene, it was marketed as the “Uber of Cannabis”—a tech-enabled delivery platform that promised to professionalize and scale legal access across California. At its peak, Eaze ...
Arizona Ballot Measure Targets Cannabis Retail Shutdown
PHOENIX – A conservative-backed campaign in Arizona has launched an effort to roll back key elements of the state's adult-use Cannabis program, filing a ballot initiative last month that would shutter licensed dispensaries and end ...
Fluent Offloads Pennsylvania Dispensaries
NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...
Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors
NEW YORK- For decades, seniors managing chronic pain, inflammation, anxiety, or sleep disruption have relied largely on pharmaceuticals—often with long lists of side effects. That landscape is starting to change. Medicare is preparing to recognize cannabidiol ...
DEA Increases Psychedelics Production Quotas for 2026
WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...
Indiana Republicans Propose Statewide Oversight for Craft Hemp Market
INDIANAPOLIS – Three Republican members of the Indiana House introduced legislation this week to impose a structured permitting system on the sale and distribution of craft hemp products, a category that includes flower, beverages and ...
Wyld Acquires Grön
SEATTLE – Wyld, a leading producer of THC-CBD-infused gummies and chocolates, announced its agreement to acquire Grön, a Portland-based maker of sugar-coated pearls and confections, in a move that unites two prominent players in the ...
